Nurix Therapeutics, Inc. NRIX

23.08 (0.57) (2.41%) as of 25 Sep
Market cap
$2.5B
P/E
0.0×
Nov '17 Nov '18 Nov '19 Nov '20 Nov '21 Nov '22 Nov '23 Nov '24 Nov '25
P/E ratio — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio — 0.00 0.00 37.49 41.55 15.59 4.39 26.44 17.45
P/FCF ratio — 1.52 1.52 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF — (4.92) (4.92) (32.61) (39.99) (15.87) 12.66 (29.59) (21.61)
P/B ratio — 0.00 0.00 2.30 3.61 1.98 1.69 2.74 2.72
EV/Sales — 0.00 0.00 21.71 31.61 7.59 0.65 15.27 10.39
EV/EBITDA — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF — (2.19) (2.19) (83.50) (10.45) (1.70) (0.56) (4.58) (3.31)
Current Ratio — 1.24 2.44 6.70 4.70 4.51 3.40 6.46 7.02
Net Debt/EBITDA — 5.49 1.89 4.50 2.69 1.79 1.96 2.93 2.14
Debt/Equity — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE — 19.94% 45.89% (37.19%) (37.05%) (55.84%) (57.10%) (53.22%) (49.63%)
ROA — (41.54%) (48.52%) (19.64%) (26.85%) (40.37%) (37.27%) (37.77%) (38.96%)
ROIC — 0.00% 0.00% (445.28%) (158.17%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets — (77.00%) (80.11%) (16.60%) (45.74%) (68.07%) (63.88%) (35.76%) (48.72%)
Average Days of Receivables — 0.00 0.00 78.78 76.12 10.39 0.00 0.00 0.00
Earnings Yield — (4.00%) (4.00%) (7.21%) (9.47%) (30.10%) (42.60%) (13.45%) (17.98%)
Free Cash Flow Yield — 65.89% 65.89% (0.69%) (7.28%) (28.57%) (26.56%) (12.61%) (17.98%)
Free Cash Flow per Share — (11.81) (0.32) (0.30) (2.10) (3.54) (1.65) (2.71) (3.04)
Book value per Share — (13.08) (17.53) 18.52 7.98 6.25 3.69 7.85 6.22
Free Cash Flow — (33.26) (1.05) (4.63) (90.03) (172.05) (89.77) (181.86) (263.47)
EV/EBIT — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates